I was going to add they also have patents over the formulations as well. Very strong position to be in as a pharma company to have control over the plants from which the drugs are extracted (the DNA is fingerprinted, the plants are cloned), the only safe and large scale method of extraction (supercritical/subcritical CO2), the exact formulation of the drugs and their application and the method of delivering the drug (mouth spray). As I say, do your research. I rate GW a strong buy.
The other thing about GW pharma. I think, from my research, that they may be extracting the active compounds from the cannabis using a very high tech method called supercritical co2. You see at a certain temperature and pressure CO2 gas exists in a state which is neither a gas nor a solid and becomes a super solvent. It can then be used to extract compounds from the cannabis. It is an extremely clean method of extraction as it leaves no residue and it would make it very easy to scale up production and produce huge quantities of the drugs relatively easily. GW has patents/licensing over the plants, I think they have patents over the extraction methods and the method of delivery too (mouth spray).
This LSE BB is regarding GWP,not puerile glib hogwash directed towards individuals. Yes i believed a £1 price target would again occur, that remark was wrong & i failed my GWP LSE BB test! I based £1 being revisited as over the decade i had held there was always strong support at those £1 levels with alot of resistence. Considering the share price increased 100% from 50p in just a few days! Now during the previous 5 months the yanks have gone to pot which has directly pulled GW share price to revisit close to £2. It's been a decade since i last remember GWP so high. Okay, 10% fall is not a significant correction, but it was a dip & yesterday when i made my comment,I had dumped several thousand & at £1.64 I got more back. We're all in GW to make some money & for the sick to be helped. i like the rest want GW to succeed but along the way there will be corrections & oportunities to make money. I'm experienced at this now hence my top slice, but im always eager to learn new strategies. Now I'm just invested in GWP with "free" shares & when I believe a retraction looming, I will sell & buy back for less. My only error was stating £1 would again occur when only £1.29 did & yesterday stating a significant correction which was only 10%. Although on both counts a dip occurred. DYOR
The current share price is what £1.76 with a market cap of just over £300 million. I think its got a long way to go. New drugs are very expensive and profitable. Compare with say Humira which is a novel new drug and costs about £10,000 a year. Sativex also is expensive and profitable, sales were up 25% this quarter but markets are only starting to open up. I'm not an analyst, but I think a market cap in the low billions is entirely possible, as is a takeover. The current price seems low to me given the potential. Medicines are big business and very profitable.
See my previous posts over the years. I was beginning to think my wife and I might sell at about £3, but the latest figs and prospects suggest this would be silly. £5 more realistic, but I suspect we may see a takeover within two years and a subsequent auction. No surrender remains our watchword(s)
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.